RecruitingNot Applicable

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

Turkey (Türkiye)100 participantsStarted 2026-03-15

Plain-language summary

This study evaluates the effectiveness of an AI-generated therapeutic storytelling video on pre-procedural anxiety and fear levels in children aged 4 to 10 years undergoing their first Skin Prick Test (SPT). The study aims to determine if watching a cognitive preparation video at home prior to the appointment reduces anxiety compared to standard care. Participants will be randomized into two groups: an intervention group watching the AI-generated video and a control group receiving standard clinic care

Who can participate

Age range

4 Years – 10 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged between 4 and 10 years (from 4th birthday to 11th birthday). * Children undergoing a Skin Prick Test (SPT) for the first time. * Presence of suspected Allergic Rhinitis and/or Asthma. * Cognitive ability to understand Turkish, follow the video story, and interpret visual assessment scales. * Parents with internet access to view the digital content. * Obtained parental informed consent and child assent (for ages 7 and above) Exclusion Criteria: * Previous experience with Skin Prick Testing or a history of frequent medical procedures (e.g., frequent blood draws, surgeries) due to chronic illness. * Diagnosed with Autism Spectrum Disorder, severe ADHD(attention deficit hyperactivity disorder), intellectual disability, or severe psychiatric conditions preventing cooperation. * Significant visual or hearing impairments that prevent engagement with the video content. * Use of anxiolytics, sedatives, or medications affecting cognitive functions within the last 24 hours. * Chronic health problems (e.g., malignancy, immunodeficiency) that may elevate baseline anxiety levels. * Patients undergoing SPT for suspected Food Allergy, Drug Allergy, or Bee Venom Allergy. * For the intervention group: Failure to watch the video or answering the three "validation questions" incorrectly on the procedure day.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Baseline Anxiety Level

Timeframe: Baseline

Acute Procedural Fear Level

Timeframe: Immediately post-procedure

Trial details

NCT IDNCT07453615

SponsorAntalya Training and Research Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-07-15

Contact for this trial

Enes Enes, MD

+905467328454 enesonkn@gmail.com

View on ClinicalTrials.gov More Anxiety trials